See more : Lasertec Corporation (6920.T) Income Statement Analysis – Financial Results
Complete financial analysis of Shanghai Kindly Enterprise Development Group Co.,LTD. (603987.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Shanghai Kindly Enterprise Development Group Co.,LTD., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Arata Corporation (2733.T) Income Statement Analysis – Financial Results
- Capital Power Corporation (CPX.TO) Income Statement Analysis – Financial Results
- Generex Biotechnology Corporation (GNBT) Income Statement Analysis – Financial Results
- BeiJing Seeyon Internet Software Corp. (688369.SS) Income Statement Analysis – Financial Results
- Xerox Holdings Corporation (0A6Y.L) Income Statement Analysis – Financial Results
Shanghai Kindly Enterprise Development Group Co.,LTD. (603987.SS)
About Shanghai Kindly Enterprise Development Group Co.,LTD.
Shanghai Kindly Enterprise Development Group Co.,LTD. produces and sells disposable medical polymer devices worldwide. It offers syringes, infusion sets, transfusion sets, medical tubes, needles and cannulas, and medical bags. The company also provides medical package materials, including PPPE composite films, medical packing films, sterilization indicator strips and Bowie Dick test packs, sterilization indicator tapes, medical wrapping papers, paper bags, and sterilization reels; and intervention accessories, such as guide wire, Y-connectors, inflation device, mainfold kit, pressure bandages, angiography syringes, stopcocks, sterile seldinger needle, introducer sets and tool kits, pressure transducer, extension tube, seldinger needles, hemostasis balloons, extension lines with needle free valves, pressure monitoring tubing products, and spine tool kits, as well as guiding, micro, and angiography catheters. In addition, it offers self-sealing pouches, tyverk reels, mini-spikes, PE extension tubes, suction catheter kits, irrigation kits, heparin caps, and umbilical cord clamps. Further, the company provides accessories, such as umbilical cord clamps, safety box, and stopcocks; and medical kits includes suction catheter and irrigation kits, and puncture sets. The company was founded in 1987 and is headquartered in Shanghai, China.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 2.45B | 3.12B | 3.10B | 2.65B | 1.82B | 1.45B | 1.26B | 1.13B | 1.06B | 982.79M | 931.95M | 882.93M | 775.52M |
Cost of Revenue | 1.66B | 2.07B | 1.91B | 1.62B | 1.13B | 944.60M | 836.22M | 757.71M | 734.09M | 706.92M | 675.74M | 642.66M | 558.55M |
Gross Profit | 796.50M | 1.05B | 1.19B | 1.02B | 688.29M | 505.46M | 420.18M | 374.37M | 327.32M | 275.87M | 256.21M | 240.27M | 216.97M |
Gross Profit Ratio | 32.48% | 33.68% | 38.38% | 38.58% | 37.88% | 34.86% | 33.44% | 33.07% | 30.84% | 28.07% | 27.49% | 27.21% | 27.98% |
Research & Development | 100.55M | 123.00M | 165.43M | 124.24M | 89.13M | 73.57M | 52.77M | 49.01M | 47.70M | 42.09M | 43.10M | 36.67M | 0.00 |
General & Administrative | 40.87M | 50.20M | 66.86M | 52.59M | 36.42M | 28.11M | 22.35M | 22.77M | 18.78M | 17.81M | 22.80M | 100.71M | 77.64M |
Selling & Marketing | 226.84M | 309.44M | 309.88M | 303.74M | 182.82M | 118.28M | 94.03M | 82.79M | 67.84M | 55.31M | 51.43M | 43.52M | 29.53M |
SG&A | 267.71M | 359.64M | 376.74M | 356.32M | 219.24M | 146.39M | 116.38M | 105.56M | 86.62M | 73.12M | 74.23M | 144.22M | 107.18M |
Other Expenses | -234.60K | 172.04M | 174.92M | 139.28M | 111.19M | 6.68M | 11.48M | 8.69M | 11.00M | 9.02M | 51.96M | 6.34M | 5.14M |
Operating Expenses | 495.50M | 654.68M | 717.09M | 619.84M | 419.56M | 319.48M | 250.13M | 228.53M | 198.45M | 180.60M | 180.64M | 148.88M | 110.27M |
Cost & Expenses | 2.15B | 2.72B | 2.63B | 2.24B | 1.55B | 1.26B | 1.09B | 986.25M | 932.54M | 887.52M | 856.38M | 791.54M | 668.82M |
Interest Income | 6.42M | 8.28M | 17.66M | 29.50M | 14.79M | 4.86M | 3.17M | 866.69K | 887.18K | 1.58M | 259.02K | 22.84M | -0.41 |
Interest Expense | 26.48M | 28.16M | 24.19M | 20.65M | 14.69M | 440.44K | 1.99M | 17.94M | 17.42M | 22.15M | 23.60M | 0.00 | 18.64M |
Depreciation & Amortization | 161.42M | 163.78M | 154.51M | 136.27M | 89.90M | 75.22M | 71.96M | 67.80M | 62.05M | 59.39M | 48.19M | 43.06M | 34.24M |
EBITDA | 452.79M | 568.65M | 664.07M | 549.40M | 388.20M | 285.22M | 246.82M | 231.09M | 211.77M | 168.62M | 123.76M | 134.45M | 140.95M |
EBITDA Ratio | 18.46% | 19.41% | 20.82% | 20.78% | 20.98% | 19.56% | 19.61% | 20.29% | 19.95% | 17.24% | 18.68% | 15.44% | 18.50% |
Operating Income | 301.00M | 399.46M | 478.01M | 380.46M | 282.24M | 201.37M | 160.88M | 136.80M | 120.08M | 76.98M | 50.18M | 66.96M | 86.54M |
Operating Income Ratio | 12.27% | 12.81% | 15.43% | 14.38% | 15.53% | 13.89% | 12.80% | 12.08% | 11.31% | 7.83% | 5.38% | 7.58% | 11.16% |
Total Other Income/Expenses | -517.60K | -79.06K | 5.73M | 9.57M | 8.03M | 7.28M | 11.48M | 7.16M | 10.06M | 8.05M | 30.36M | -18.92M | 4.22M |
Income Before Tax | 300.48M | 399.38M | 483.74M | 390.17M | 288.91M | 208.65M | 172.36M | 144.79M | 130.14M | 85.03M | 80.54M | 72.70M | 90.76M |
Income Before Tax Ratio | 12.25% | 12.81% | 15.62% | 14.75% | 15.90% | 14.39% | 13.72% | 12.79% | 12.26% | 8.65% | 8.64% | 8.23% | 11.70% |
Income Tax Expense | 24.06M | 25.26M | 64.53M | 63.84M | 40.35M | 28.20M | 29.33M | 23.42M | 18.73M | 12.46M | 12.79M | 11.88M | 12.24M |
Net Income | 230.90M | 311.74M | 419.21M | 326.33M | 248.56M | 147.09M | 118.96M | 100.71M | 94.55M | 64.48M | 63.31M | 56.97M | 75.28M |
Net Income Ratio | 9.41% | 10.00% | 13.54% | 12.34% | 13.68% | 10.14% | 9.47% | 8.90% | 8.91% | 6.56% | 6.79% | 6.45% | 9.71% |
EPS | 0.53 | 0.71 | 0.95 | 0.74 | 0.57 | 0.33 | 0.27 | 0.29 | 0.29 | 0.20 | 0.19 | 0.17 | 0.23 |
EPS Diluted | 0.53 | 0.71 | 0.95 | 0.74 | 0.57 | 0.33 | 0.27 | 0.29 | 0.29 | 0.20 | 0.19 | 0.17 | 0.23 |
Weighted Avg Shares Out | 435.67M | 441.57M | 441.51M | 440.81M | 436.17M | 441.61M | 440.58M | 352.48M | 330.92M | 330.25M | 332.31M | 332.30M | 329.33M |
Weighted Avg Shares Out (Dil) | 435.67M | 441.57M | 441.51M | 440.81M | 436.17M | 445.74M | 440.58M | 352.48M | 330.92M | 330.25M | 332.35M | 332.30M | 329.33M |
Source: https://incomestatements.info
Category: Stock Reports